2018

Distinc genetic diversity of carbapanem-resistant Acinetobacter baumannii from Colombian hospitals

Correa A; Del Campo R; Escandón-Vargas K; Perenguez M; Rodriguez-Baños M; Hernández-Gomez C; Pallares C; Perez F; Arias CA; Cantón R; Villegas MV

2015

DNA-containing immunocomplexes promote inflammasome assembly and release of pyrogenic cytokines by CD14+ CD16+ CD64high CD32low inflammatory monocytes from malaria patients

Hirakoa IC; Gallego-Marín C; Ataide MA; Andrade WA; Gravina H; Rocha BC; de Oliveira RB; Pereira DB; Vinetz J; Diamond B; Ramb S; Golenboch DT; Gazzinelli RT.

2019

Eligibility for local therapies in adolescents and adults with cutaneous leishmaniasis from southwestern Colombia: a cross-sectional study

Uribe-Restrepo A; Prieto MD; Cossio A; Mayur D; Castro MM

2013

Emergence of Klebsiella pneumoniae Co-harboring KPC and VIM Carbapenemases in Colombia

Rojas LJ; Mojica MF; Blanco VM; Correa A; Montealegre MC; De La Cadena E; Maya JJ; Camargo RD; Quinn JP; Villegas MV

2014

Emergence of OXA-72-producing Acinetobacter pittii clinical isolates.

Bonnina RA; Docobo-Péreza F; Poirela L; Villegas MV

2014

Emergence of resistance to miltefosine following treatment of dermal leishmaniasis.

Obonaga R; Fernández O; Valderrama L; Rubiano LC; Castro MM; Barrera MC; Gómez MA; Saravia NG.

2012

Environmental factors associated with American cutaneous leishmaniasis in a new Andean focus in Colombia.

Ocampo CB; Ferro MC; Cadena H; Gongora R; Pérez M; Valderrama-Ardila CH, Quinnell RJ, Alexander N.

2016

Epidemiology of candida isolates from Intensive Care Units in Colombia from 2010 to 2013

Motoa G; Muñoz JS; Oñate J; Pallares CJ; Hernandez C; Villegas MV

2017

Epidemiology of candida isolates from Intensive Care Units in Colombia from 2010 to 2013

Motoa G; Muñoz JS; Oñate J; Pallares CJ; Hernandez C; Villegas MV.

2013

Estrategias para la implementación y reporte de los puntos de corte CLSI vigentes y pruebas fenotípicas confirmatorias para BLEE y carbapenemasas en bacilos Gram negativos en laboratorios clínicos de Colombia

Esparza G; Ariza B; Bedoya AM; Bustos AM; Catañeda-Ramírez CR; De la Cedena E; González de Arias MN; Guerrero L; Leal AL; Marín A; Meléndez MP; Rico CL; Villegas MV and Comité de Resistencia Bacteriana e IAAS ACIN